DexCom (DXCM) Tops Q4 EPS by 37c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Dexcom Reports Fourth Quarter and Fiscal Year 2018 Financial Results
February 21, 2019 4:10 PM ESTThe Company also Announces Expansion and Reorganization of its Customer Support Functions
SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December31, 2018.
Fourth Quarter 2018 Highlights:
Revenue grew 53% versus the same quarter of the prior year to $338.0 million U.S. revenue growth of 50% and international revenue growth of 72% Advanced next generation pipeline and improved future profitability profile with amended Verily collaboration Strengthened balance sheet to provide increased financial and... More